From Wrist to Wellbeing: How Wearables Are Reshaping Personalized Healthcare
Keywords:
Wearable Devices, Personalized Medicine, Artificial Intelligence, Continuous Glucose Monitoring, Digital BiomarkersAbstract
Wearable devices carry physiological monitoring out of the clinic and into everyday life, yet their value for personalized healthcare lies in how recorded signals are interpreted and acted upon. This narrative review explores clinical applications, artificial intelligence, barriers to implementation, and priorities for future research across cardiovascular care, diabetes, neurology, sleep, physical activity, infection surveillance, and biochemical sensing. Literature was identified through structured PubMed searches, selected purposively, and synthesized thematically, with foundational methodological studies and current regulatory guidance added for context. Each body of evidence was appraised for measurement validity, diagnostic or prognostic accuracy, demonstrated clinical utility, and practical feasibility. The strongest therapeutic evidence comes from continuous glucose monitoring and automated insulin delivery, where randomized trials link wearable-derived data to better glycemic control in specific populations. Large smartwatch studies show that detecting possible atrial fibrillation is feasible, but the accuracy of alerts, the yield of follow-up diagnostic testing, and the prevention of clinical events are distinct questions that remain open. In neurology and sleep, wearables offer valuable longitudinal data, though performance differs by population, outcome measure, and device version. External validation of Parkinson's disease prediction models shows how difficult it is to carry promising findings from one cohort to another. Sweat-based sensors expand the range of measurable biochemical markers, but evidence that they change treatment decisions is still limited. Across all domains, missing data, unreliable calibration, inequitable access, privacy risks, and unclear clinical accountability can undermine otherwise capable systems. Effective personalization therefore depends on validated measurements, transparent handling of uncertainty, accessible care pathways, and treatment plans that patients can maintain over time. Future research should prioritize prospective external validation, comparative effectiveness studies, patient-centered outcomes, transparent control of software changes, and independent evaluation of long-term costs and harms.